A detailed history of Provident Investment Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Provident Investment Management, Inc. holds 16,175 shares of ABT stock, worth $1.9 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
16,175
Previous 15,407 4.98%
Holding current value
$1.9 Million
Previous $1.6 Million 15.25%
% of portfolio
0.18%
Previous 0.15%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$100.07 - $118.13 $76,853 - $90,723
768 Added 4.98%
16,175 $1.84 Million
Q2 2024

Aug 07, 2024

BUY
$100.73 - $112.44 $97,607 - $108,954
969 Added 6.71%
15,407 $1.6 Million
Q1 2024

May 14, 2024

BUY
$109.52 - $120.96 $115,105 - $127,128
1,051 Added 7.85%
14,438 $1.64 Million
Q4 2023

Feb 12, 2024

BUY
$90.19 - $110.4 $289,960 - $354,936
3,215 Added 31.61%
13,387 $1.47 Million
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $325,757 - $390,854
3,410 Added 50.43%
10,172 $985,000
Q1 2023

May 15, 2023

SELL
$96.86 - $114.01 $55,597 - $65,441
-574 Reduced 7.82%
6,762 $684,000
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $18,631 - $21,857
196 Added 2.75%
7,336 $805,000
Q2 2022

Aug 11, 2022

SELL
$102.07 - $123.37 $42,767 - $51,692
-419 Reduced 5.54%
7,140 $775,000
Q1 2022

May 16, 2022

SELL
$114.02 - $139.04 $15,164 - $18,492
-133 Reduced 1.73%
7,559 $895,000
Q4 2021

Feb 11, 2022

SELL
$115.53 - $141.46 $4,159 - $5,092
-36 Reduced 0.47%
7,692 $1.08 Million
Q3 2021

Nov 10, 2021

SELL
$116.66 - $129.06 $20,765 - $22,972
-178 Reduced 2.25%
7,728 $913,000
Q2 2021

Aug 06, 2021

SELL
$105.79 - $124.53 $68,234 - $80,321
-645 Reduced 7.54%
7,906 $917,000
Q4 2020

Feb 10, 2021

SELL
$105.0 - $114.42 $55,125 - $60,070
-525 Reduced 5.78%
8,551 $936,000
Q3 2020

Nov 05, 2020

SELL
$91.64 - $111.29 $114,550 - $139,112
-1,250 Reduced 12.11%
9,076 $988,000
Q2 2020

Aug 11, 2020

BUY
$76.57 - $98.0 $9,188 - $11,760
120 Added 1.18%
10,326 $944,000
Q1 2020

May 04, 2020

BUY
$62.82 - $91.86 $9,360 - $13,687
149 Added 1.48%
10,206 $805,000
Q4 2019

Feb 10, 2020

BUY
$78.51 - $87.4 $15,702 - $17,480
200 Added 2.03%
10,057 $874,000
Q3 2019

Nov 06, 2019

SELL
$81.84 - $88.74 $159,588 - $173,043
-1,950 Reduced 16.52%
9,857 $825,000
Q2 2019

Aug 08, 2019

SELL
$72.88 - $85.0 $3,644 - $4,250
-50 Reduced 0.42%
11,807 $993,000
Q1 2019

May 13, 2019

SELL
$66.22 - $80.06 $9.1 Million - $11 Million
-137,477 Reduced 92.06%
11,857 $948,000
Q4 2018

Feb 11, 2019

SELL
$65.56 - $74.27 $565,782 - $640,950
-8,630 Reduced 5.46%
149,334 $10.8 Million
Q3 2018

Nov 13, 2018

SELL
$60.81 - $73.36 $9.67 Million - $11.7 Million
-158,965 Reduced 50.16%
157,964 $11.6 Million
Q2 2018

Aug 09, 2018

SELL
$57.57 - $63.54 $7.89 Million - $8.71 Million
-137,114 Reduced 30.2%
316,929 $19.3 Million
Q1 2018

Apr 23, 2018

SELL
$56.27 - $63.62 $1.22 Million - $1.37 Million
-21,598 Reduced 4.54%
454,043 $27.2 Million
Q4 2017

Feb 06, 2018

SELL
$53.68 - $57.47 $927,375 - $992,851
-17,276 Reduced 3.5%
475,641 $27.1 Million
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $23.7 Million - $26.4 Million
492,917
492,917 $26.3 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Provident Investment Management, Inc. Portfolio

Follow Provident Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Provident Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Provident Investment Management, Inc. with notifications on news.